Edirol (eldecalcitol) / Roche, Taisho 
Welcome,         Profile    Billing    Logout  
 4 Diseases   3 Trials   3 Trials   92 News 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Edirol (eldecalcitol) / Roche, Taisho
ELEGANT, NCT06385093: A Study on the Prevention and Treatment of GIOP With Eldecalcitol

Not yet recruiting
4
314
RoW
Eldecalcitol capsules, Edirol, Alfacalcidol tablets, Calcium carbonate tablets
Chinese SLE Treatment And Research Group, Beijing Life oasis public service center
Rheumatoid Arthritis, Osteoporosis, Osteopenia
12/25
03/26
NCT06537115: Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia

Recruiting
4
450
RoW
exercise, whey protein powder, Eldecalcitol
Zhejiang Provincial People's Hospital
Sarcopenia
05/26
05/27
ChiCTR2200066283: Efficacy and ADR monitoring of Eldecalcitol in the treatment of postmenopausal and diabetic osteoporosis

Not yet recruiting
4
50
 
N/A ;N/A
The Seventh Affiliated Hospital of Sun Yat-Sen University; The Seventh Affiliated Hospital of Sun Yat-Sen University, Three engineering projects in Department of Endocrinology
Osteoporosis
 
 
NCT05884372: Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.

Recruiting
4
100
RoW
Eldecalcitol, Native Vitamin D, Denosumab, Calcium
Xi'an Honghui Hospital, Chugai Pharma China Co., Ltd.
Osteoporosis in Postmenopausal Women
12/24
06/25
ChiCTR2300070456: Comparison of the efficacy and safety between eldecalcitol and calcitriol in postmenopausal women with low bone mineral density and mild osteoporosis

Not yet recruiting
4
300
 
Orally 0.75 μg qd Eldecalcitol ;Orally 0.5 μg qd Calcitriol
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, Chugai Pharma
Osteoporosis
 
 
EFFECT, NCT05902078: Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

Recruiting
4
300
RoW
Eldecalcitol capsules, Edirol, Calcitriol capsules, Haidewei
Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Chugai Pharma China Co., Ltd.
Low Bone Mineral Density, Postmenopausal Osteoporosis
06/25
12/25
ChiCTR2400085142: Clinical intervention of idecalcitol combined with whey protein powder and exercise for sarcopenia

Not yet recruiting
4
600
 
After enrollment, professional doctors will conduct a comprehensive assessment of their basic conditions and provide routine interventions, mainly including basic nutrition intervention program guidance, progressive resistance exercise intervention program guidance, safety protection advice, and symptomatic treatment for different complications, with a total intervention period of 24 weeks.; On the basis of the control group, whey protein powder was given to supplement for 12 weeks.60 grams of protein per day is taken in three divided doses for 12 consecutive weeks. Attention should be paid to monitoring liver and kidney function, and the dosage of protein powder should be adjusted according to the condition of the patient.; On the basis of the control group, whey protein powder and eldecalcitol were given for supplementation for 12 weeks.(Supplementing whey protein powder: The protein intake is 60 grams per day, taken in three divided doses for 12 consecutive weeks. Attention should be paid to monitoring liver and kidney function, and the dosage of protein powder should be adjusted according to the condition of the patient.Supplementing eldecalcitol: eldecalcitol soft gel capsules are taken at an oral dose of 0.75μg once a day for 12 consecutive weeks.)
Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital, Funded by Zhejiang Provincial People's Hospital
sarcopenia
 
 
NCT03755193: Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

Recruiting
2
90
Japan
SERM "Viviant®Tablet 20mg" and ELD "Edirol®Tablet 0.75ug", Bisphosphonates and ELD "Edirol®Tablet 0.75ug", ELD "Edirol®Tablet 0.75ug"
Shinshu University
Osteoporosis
11/24
11/26
NCT02306187: The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis

Recruiting
1
100
Japan
Edirol, Eldecalcitol
Shinshu University
Osteoporosis
12/22
12/24
NCT05433207: Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Not yet recruiting
N/A
1000
RoW
Eldecalcitol soft capsules
Chugai Pharmaceutical
Postmenopausal Osteoporosis
01/25
01/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Edirol (eldecalcitol) / Roche, Taisho
ELEGANT, NCT06385093: A Study on the Prevention and Treatment of GIOP With Eldecalcitol

Not yet recruiting
4
314
RoW
Eldecalcitol capsules, Edirol, Alfacalcidol tablets, Calcium carbonate tablets
Chinese SLE Treatment And Research Group, Beijing Life oasis public service center
Rheumatoid Arthritis, Osteoporosis, Osteopenia
12/25
03/26
NCT06537115: Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia

Recruiting
4
450
RoW
exercise, whey protein powder, Eldecalcitol
Zhejiang Provincial People's Hospital
Sarcopenia
05/26
05/27
ChiCTR2200066283: Efficacy and ADR monitoring of Eldecalcitol in the treatment of postmenopausal and diabetic osteoporosis

Not yet recruiting
4
50
 
N/A ;N/A
The Seventh Affiliated Hospital of Sun Yat-Sen University; The Seventh Affiliated Hospital of Sun Yat-Sen University, Three engineering projects in Department of Endocrinology
Osteoporosis
 
 
NCT05884372: Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.

Recruiting
4
100
RoW
Eldecalcitol, Native Vitamin D, Denosumab, Calcium
Xi'an Honghui Hospital, Chugai Pharma China Co., Ltd.
Osteoporosis in Postmenopausal Women
12/24
06/25
ChiCTR2300070456: Comparison of the efficacy and safety between eldecalcitol and calcitriol in postmenopausal women with low bone mineral density and mild osteoporosis

Not yet recruiting
4
300
 
Orally 0.75 μg qd Eldecalcitol ;Orally 0.5 μg qd Calcitriol
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, Chugai Pharma
Osteoporosis
 
 
EFFECT, NCT05902078: Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

Recruiting
4
300
RoW
Eldecalcitol capsules, Edirol, Calcitriol capsules, Haidewei
Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Chugai Pharma China Co., Ltd.
Low Bone Mineral Density, Postmenopausal Osteoporosis
06/25
12/25
ChiCTR2400085142: Clinical intervention of idecalcitol combined with whey protein powder and exercise for sarcopenia

Not yet recruiting
4
600
 
After enrollment, professional doctors will conduct a comprehensive assessment of their basic conditions and provide routine interventions, mainly including basic nutrition intervention program guidance, progressive resistance exercise intervention program guidance, safety protection advice, and symptomatic treatment for different complications, with a total intervention period of 24 weeks.; On the basis of the control group, whey protein powder was given to supplement for 12 weeks.60 grams of protein per day is taken in three divided doses for 12 consecutive weeks. Attention should be paid to monitoring liver and kidney function, and the dosage of protein powder should be adjusted according to the condition of the patient.; On the basis of the control group, whey protein powder and eldecalcitol were given for supplementation for 12 weeks.(Supplementing whey protein powder: The protein intake is 60 grams per day, taken in three divided doses for 12 consecutive weeks. Attention should be paid to monitoring liver and kidney function, and the dosage of protein powder should be adjusted according to the condition of the patient.Supplementing eldecalcitol: eldecalcitol soft gel capsules are taken at an oral dose of 0.75μg once a day for 12 consecutive weeks.)
Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital, Funded by Zhejiang Provincial People's Hospital
sarcopenia
 
 
NCT03755193: Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

Recruiting
2
90
Japan
SERM "Viviant®Tablet 20mg" and ELD "Edirol®Tablet 0.75ug", Bisphosphonates and ELD "Edirol®Tablet 0.75ug", ELD "Edirol®Tablet 0.75ug"
Shinshu University
Osteoporosis
11/24
11/26
NCT02306187: The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis

Recruiting
1
100
Japan
Edirol, Eldecalcitol
Shinshu University
Osteoporosis
12/22
12/24
NCT05433207: Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Not yet recruiting
N/A
1000
RoW
Eldecalcitol soft capsules
Chugai Pharmaceutical
Postmenopausal Osteoporosis
01/25
01/25

Download Options